RARE vs SUN · rev $560.2M vs P/E 16, rev $22.69B
Ultragenyx (RARE) versus Sunoco LP (SUN) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Sunoco LP (SUN) is a oil & gas refining & marketing company listed on NYSE.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
Latest reported SUN revenue for 2024-12-31 was $22.69B. Net income was $874.0M. Revenue was down 1.6% from 2023-12-31 to 2024-12-31. SUN currently screens at market cap $11.84B and trailing P/E 16.0.
RARE currently screens at market cap $2.79B. SUN currently screens at market cap $11.84B and trailing P/E 16.0.
Not investment advice. Open the RARE and SUN stock pages for the full models.
Not investment advice.